339 related articles for article (PubMed ID: 27556586)
1. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
Resende LA; Aguiar-Soares RD; Gama-Ker H; Roatt BM; Mendonça LZ; Alves ML; Silveira-Lemos Dd; Corrêa-Oliveira R; Martins-Filho OA; Araújo MS; Fujiwara RT; Gontijo NF; Reis AB; Giunchetti RC
PLoS One; 2016; 11(8):e0161169. PubMed ID: 27556586
[TBL] [Abstract][Full Text] [Related]
2. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
Aguiar-Soares RD; Roatt BM; Ker HG; Moreira Nd; Mathias FA; Cardoso JM; Gontijo NF; Bruna-Romero O; Teixeira-Carvalho A; Martins-Filho OA; Corrêa-Oliveira R; Giunchetti RC; Reis AB
Parasit Vectors; 2014 Feb; 7():61. PubMed ID: 24507702
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
[TBL] [Abstract][Full Text] [Related]
4. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
[TBL] [Abstract][Full Text] [Related]
5. Cytokine and nitric oxide patterns in dogs immunized with LBSap vaccine, before and after experimental challenge with Leishmania chagasi plus saliva of Lutzomyia longipalpis.
Resende LA; Roatt BM; Aguiar-Soares RD; Viana KF; Mendonça LZ; Lanna MF; Silveira-Lemos D; Corrêa-Oliveira R; Martins-Filho OA; Fujiwara RT; Carneiro CM; Reis AB; Giunchetti RC
Vet Parasitol; 2013 Dec; 198(3-4):371-81. PubMed ID: 24129068
[TBL] [Abstract][Full Text] [Related]
6. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.
Roatt BM; Aguiar-Soares RD; Vitoriano-Souza J; Coura-Vital W; Braga SL; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; de Lana M; Figueiredo Gontijo N; Marques MJ; Giunchetti RC; Reis AB
PLoS One; 2012; 7(11):e49780. PubMed ID: 23189161
[TBL] [Abstract][Full Text] [Related]
7. Immunization of Experimental Dogs With Salivary Proteins From
Abbehusen MMC; Cunha J; Suarez MS; Teixeira C; Almeida VDA; Pereira LDS; Bordoni M; Gil-Santana L; Solcà MDS; Fraga DBM; Fischer L; Bozza PT; Veras PST; Valenzuela JG; Kamhawi S; Andrade BB; Brodskyn CI
Front Immunol; 2018; 9():2558. PubMed ID: 30519235
[TBL] [Abstract][Full Text] [Related]
8. Canine Leishmania vaccines: still a long way to go.
Gradoni L
Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
[TBL] [Abstract][Full Text] [Related]
9. Systemic and compartmentalized immune response in canine visceral leishmaniasis.
Reis AB; Martins-Filho OA; Teixeira-Carvalho A; Giunchetti RC; Carneiro CM; Mayrink W; Tafuri WL; Corrêa-Oliveira R
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):87-95. PubMed ID: 19054576
[TBL] [Abstract][Full Text] [Related]
10. T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.
Araújo MS; de Andrade RA; Sathler-Avelar R; Teixeira-Carvalho A; Andrade MC; Vianna LR; Mayrink W; Reis AB; Malaquias LC; Mello MN; Martins-Filho OA
Vaccine; 2009 Feb; 27(7):1008-17. PubMed ID: 19110023
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.
Petitdidier E; Pagniez J; Papierok G; Vincendeau P; Lemesre JL; Bras-Gonçalves R
PLoS Negl Trop Dis; 2016 May; 10(5):e0004614. PubMed ID: 27223609
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
[TBL] [Abstract][Full Text] [Related]
13. Use of Phage Display technology in development of canine visceral leishmaniasis vaccine using synthetic peptide trapped in sphingomyelin/cholesterol liposomes.
Toledo-Machado CM; Bueno LL; Menezes-Souza D; Machado-de-Avila RA; Nguyen C; Granier C; Bartholomeu DC; Chávez-Olórtegui C; Fujiwara RT
Parasit Vectors; 2015 Feb; 8():133. PubMed ID: 25889286
[TBL] [Abstract][Full Text] [Related]
14. Parasite load induces progressive spleen architecture breakage and impairs cytokine mRNA expression in Leishmania infantum-naturally infected dogs.
Cavalcanti AS; Ribeiro-Alves M; Pereira Lde O; Mestre GL; Ferreira AB; Morgado FN; Boité MC; Cupolillo E; Moraes MO; Porrozzi R
PLoS One; 2015; 10(4):e0123009. PubMed ID: 25875101
[TBL] [Abstract][Full Text] [Related]
15. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.
Giunchetti RC; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; Roatt BM; de Oliveira Aguiar-Soares RD; Coura-Vital W; de Abreu RT; Malaquias LC; Gontijo NF; Brodskyn C; de Oliveira CI; Costa DJ; de Lana M; Reis AB
Vaccine; 2008 Jan; 26(5):623-38. PubMed ID: 18180079
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TNF-α, IL-4, and IL-10 and parasite density in spleen and liver of L. (L.) chagasi naturally infected dogs.
DE F Michelin A; Perri SH; De Lima VM
Ann Trop Med Parasitol; 2011 Jul; 105(5):373-83. PubMed ID: 21929879
[TBL] [Abstract][Full Text] [Related]
17. Immunoprophylactic Potential of a New Recombinant
Pessoa-E-Silva R; Trajano-Silva LAM; Vaitkevicius-Antão V; Dos Santos WJT; Magalhães FB; Moura DMN; Nakasone EKN; de Lorena VMB; de Paiva-Cavalcanti M
Front Immunol; 2020; 11():605044. PubMed ID: 33488607
[TBL] [Abstract][Full Text] [Related]
18. Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis.
Costa DJ; Carvalho RM; Abbehusen M; Teixeira C; Pitombo M; Trigo J; Nascimento F; Amorim L; Abreu-Silva AL; do Socorro Pires Cruz M; Miranda JC; Fukutani K; de Oliveira CI; Barral A; Barral-Netto M; Brodskyn C
PLoS One; 2013; 8(4):e60535. PubMed ID: 23577121
[TBL] [Abstract][Full Text] [Related]
19. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
[TBL] [Abstract][Full Text] [Related]
20. Diminished CD4+/CD25+ T cell and increased IFN-gamma levels occur in dogs vaccinated with Leishmune in an endemic area for visceral leishmaniasis.
de Lima VM; Ikeda FA; Rossi CN; Feitosa MM; Vasconcelos RO; Nunes CM; Goto H
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):296-302. PubMed ID: 20132994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
